Abstract
Docetaxel is a new taxoid widely used in chemotherapy for advanced breast cancer and other solid malignancies. Painful nail changes with onycholysis occur in about 40% of docetaxel-treated patients as a prominent adverse effect. We report a patient with a complete peripheral palsy of the right arm due to advanced breast cancer with diffuse tumor infiltration of the brachial plexus. Treatment with docetaxel led to onycholysis at all extremities except the paretic hand. Sensory and motoric innervation measured by nerve conduction studies showed a complete loss of large nerve fiber function of the right arm. Function of deep mechanosensitive Aβ-fibers (quantitative vibrametry) was severely decreased, but not absent. Sympathetic reflexes (induced by deep inspiration and measured with laser Doppler flowmetry) were absent on the right side and skin temperature was decreased consistent with a complete sympathetic denervation. Small afferent fibers investigated by quantitative thermotesting revealed a total loss of thermal and pain sensation. Furthermore, iontophoresis of histamine failed to induce any axon reflex-vasodilatation indicating a complete peripheral degeneration of small fiber afferents. In summary, a severe denervation of small and large fibers of the right upper limb was revealed. These results indicate that integrity of peripheral nerves seems to be a substantial factor for docetaxel-mediated nail changes. The role of an inflammatory process in onycholysis maintained by postganglionic sympathetic terminals and nociceptive C-fiber afferents is discussed. In accordance with this hypothesis, a cyclooxygenase-2 inhibitor improved nail alterations of the non-paretic limbs.
Similar content being viewed by others
References
Crown J, O'Leary M: The taxanes: an update. Lancet 355: 1176–1178, 2000
Goldhirsch A, Francis P, Castiglione-Gertsch M, Gelber RD, Coates AS: Taxanes as adjuvant for breast cancer. Lancet 356: 507–508, 2000
ten Bokkel Huinink WW, Prove AM, Piccart M, Steward W, Tursz T, Wanders J, Franklin H, Clavel M, Verweij J, Alakl M: A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group. Ann Oncol 5: 527–532, 1994
Dreyfuss AI, Clark JR, Norris CM, Rossi RM, Lucarini JW, Busse PM, Poulin MD, Thornhill L, Costello R, Posner MR: Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 14: 1672–1678, 1996
Trudeau ME: Docetaxel (Taxotere): an overviewof first-line monotherapy. Semin Oncol 22: 17–21, 1995
Jacob CI, Patten SF: Nail bed dyschromia secondary to docetaxel therapy. Arch Dermatol 134: 1167–1168, 1998
Correia O, Azevedo C, Pinto Ferreira E, Braga Cruz F, Polonia J: Nail changes secondary to docetaxel (Taxotere). Dermatology 198: 288–290, 1999
Obermair A, Binder M, Barrada M, Bancher-Todesca D, Asseryanis E, Kubista E: Onycholysis in patients treated with docetaxel. Ann Oncol 9: 230–231, 1998
Flory SM, Solimando DA Jr, Webster GF, Dunton CJ, Neufeld JM, Haffey MB: Onycholysis associated with weekly administration of paclitaxel. Ann Pharmacother 33: 584–586, 1999
Hussain S, Anderson DN, Salvatti ME, Adamson B, McManus M, Braverman AS: Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature. Cancer 88: 2367–2371, 2000
Wasner G, Hilpert F, Baron R, Pfisterer J: Clinical picture: nail changes secondary to docetaxel. Lancet 357: 910, 2001
Claus D, Mustafa C, Vogel W, Herz M, Neundörfer B: Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function. Muscle Nerve 16: 757–768, 1993
Low PA, Neumann C, Dyck PJ, Fealey RD, Tuck RR: Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clin Proc 58: 583–592, 1983
Bosley PG: The concept of a capillary unit and the probable relationship of a nerve fiber, and related tissues, to the capillary in the human nailfold. Bibl Anat 7: 314–324, 1965
Jänig W, McLachlan EM: Neurobiology of the autonomic nervous system In: Mathias CJ, Sir Bannister R (eds) Autonomic Failure-A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford University Press, Oxford, 1999, pp 3–15
Bini G, Hagbarth KE, Hynninen P, Wallin BG: Thermoregulatory and rhythm-generating mechanisms governing the sudomotor and vasoconstrictor outflow in human cutaneous nerves. J Physiol (Lond) 306: 537–552, 1980
Ando Y, Araki S, Shimoda O, Kano T: Role of autonomic nerve functions in patients with familial amyloidotic polyneuropathy as analyzed by laser Doppler flowmetry, capsule hydrograph, and cardiographic R-R interval. Muscle Nerve 15: 507–512, 1992
Beck JS, Abbot NC, Samson PD, Butlin CR, Grange JM, Cree IA, Forster A, Khan F: Impairment of vasomotor reflexes in the fingertips of leprosy patients. J Neurol Neurosurg Psychiatry 54: 965–971, 1991
Schüller TB, Hermann K, Baron R: Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy. J Neurol 247: 267–272, 2000
Fruhstorfer H, Lindblom U, Schmidt WC: Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 39: 1071–1075, 1976
Yarnitsky D, Ochoa JL: Warm and cold specific somatosensory systems. Psychophysical thresholds, reaction times and peripheral conduction velocities. Brain 114: 1819-1826
Baron R, Saguer M: Postherpetic neuralgia. Are C-nociceptors involved in signalling and maintenance of tactile allodynia? Brain 116: 1477–1496, 1993
Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P, Gries FA: Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 9: 166–175, 1992
Baron R, Häbler HJ, Heckmann K, Porschke H: Respiratory modulation of blood flow in normal and sympathectomized skin in humans. J Auton Nerv Syst 60: 147–153, 1996
Baron R, Maier C: Reflex sympathetic dystrophy: skin blood flow, sympathetic vasoconstrictor reflexes and pain before and after surgical sympathectomy. Pain 67: 317–326, 1996
Butler SH: Disuse and CRPS. In Harden RN, Baron R, JänigW (eds) Complex regional pain syndrome. Progress in Pain Research and Management. IASP Press, Seattle, 2001, pp 141–150
Daniel CR 3rd, Scher RK: Nail changes secondary to systemic drugs or ingestants. J Am Acad Dermatol 10: 250–258, 1984
Lewis T: Blood Vessels of the Human Skin and Their Responses. Shaw, 1927
LaMotte RH, Lundberg LE, Torebjörk HE: Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol (Lond) 448: 749–764, 1992
Holzer P: Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121: 49–146, 1992
Ding AH, Porteu F, Sanchez E, Nathan CF: Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248: 370–372, 1990
Sorkin LS, XiaoW-H, Wagner R, Myers RR: Tumor necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neurosci 81: 255–262, 1997
Bogdan C, Ding A: Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J Leukoc Biol 52: 119–121, 1992
Green PG, Jänig W, Levine JD: Negative feedback neuroendocrine control of inflammatory response in the rat is dependent on the sympathetic postganglionic neuron. J Neurosci 17: 3234–3238, 1997
Kinnman E, Levine JD: Involvement of the sympathetic postganglionic neuron in capsaicin-induced secondary hyperalgesia in the rat. Neuroscience 65: 283–291, 1995
Schrijvers D, Wanders J, Dirix L, Prove A, Vonck I, van Oosterom A, Kaye S: Coping with toxicities of docetaxel (Taxotere). Ann Oncol 4: 610–611, 1993
Piccart MJ, Klijn J, Paridaens R, Nooij M, Mauriac L, Coleman R, Bontenbal M, Awada A, Selleslags J, Van Vreckem A, Van Glabbeke M: Corticosteroids signifi-cantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer. J Clin Oncol 15: 3149–3155, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wasner, G., Hilpert, F., Schattschneider, J. et al. Docetaxel-induced Nail Changes – A Neurogenic Mechanism: A Case Report. J Neurooncol 58, 167–174 (2002). https://doi.org/10.1023/A:1016002329546
Issue Date:
DOI: https://doi.org/10.1023/A:1016002329546